Mondadori C
Hoechst Marion Roussel, CNS Research, Bridgewater, NJ 08807-0800, USA.
Crit Rev Neurobiol. 1996;10(3-4):357-70. doi: 10.1615/critrevneurobiol.v10.i3-4.40.
This review is meant to serve several purposes. First, it surveys the preclinical and clinical profiles of piracetam-like nootropics. Second, the conditions under which the nootropics are active in preclinical studies are identified and analyzed with a view of finding a common denominator that could explain the observed effects. Third, the clinical profile is examined, on the one hand to assess whether these drugs are in fact active in humans, and on the other to determine how the clinical effects of the nootropics compare with those of tacrine. Lastly, the clinical data are then further scrutinized to assess whether they fulfill the expectations based on the preclinical findings.
本综述旨在实现多个目的。首先,它概述了吡拉西坦类益智药的临床前和临床概况。其次,确定并分析了这些益智药在临床前研究中发挥作用的条件,以期找到一个共同的因素来解释所观察到的效果。第三,对临床概况进行了研究,一方面评估这些药物在人体中是否确实有效,另一方面确定益智药的临床效果与他克林的临床效果相比如何。最后,进一步仔细审查临床数据,以评估它们是否符合基于临床前研究结果的预期。